Monthly Archives: December 2013

Targeted Medical Pharma Reports Initial Results from a Clinical Observation of Medical Foods for Children and Adults with Autistic Spectrum Disorder Symptoms

Addressing the Nutrient Deficiencies Associated with Autism Spectrum Disorders for both Children and Adults Los Angeles, CA, December 23, 2013 — Targeted Medical Pharma, Inc. (OTCQB: TRGM), announced additional preliminary findings from an investigator initiated clinical observation of amino acid based medical foods to address specific nutrient deficiencies in children and young adults with autism spectrum disease (ASD) symptoms. 34 subjects including 29 children and 5 young adults ages seven to twenty-one who were diagnosed with ASD or suffering from related symptoms including explosive behavior, Continue reading →

Targeted Medical Pharma Senior Management Buys Stock and Converts Loans to Equity

17,780 Shares Purchased on the Open Market and $1,000,000 Loan Converted to Stock Los Angeles, CA, December 18, 2013 — Targeted Medical Pharma, Inc. (OTCQB: TRGM), today announced that senior management has purchased 17,780 shares of the Company’s stock in the open market during the fourth quarter of 2013. In addition, Company CEO William Shell, M.D. also converted $1,000,000 in loans, which were made to the company in 2011 to fund production growth, into TRGM common stock. “The purchase of shares and conversion of loans Continue reading →

Targeted Medical Pharma to Present at 6th Annual LD Micro Growth Conference

Los Angeles, December 4, 2013 – Targeted Medical Pharma, Inc. (OTCQB: TRGM), today announced that members of its executive team are scheduled to present and conduct one-on-one meetings at the LD Micro Growth Conference on December 5, 2012 at 1:30 p.m. Pacific Time. The conference is being held at the Luxe Sunset Bel Air Hotel in Los Angeles, CA. About Targeted Medical Pharma, Inc. Targeted Medical Pharma, Inc., is a Los Angeles-based biotechnology company that develops  medical foods for the treatment of chronic disease, including Continue reading →